HF
CKPT

HRT Financial’s Checkpoint Therapeutics CKPT Stock Holding History

HRT Financial’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-21,329
Closed -$45K – 2509
2024
Q2 		$45K Buy
+21,329
New +$38K ﹤0.01% 1847
2024
Q1 		– Sell
-13,405
Closed -$30K – 2401
2023
Q4 		$30K Buy
+13,405
New +$29.2K ﹤0.01% 2003
2022
Q3 		– Sell
-1,140
Closed -$11K – 2879
2022
Q2 		$11K Buy
+1,140
New +$14.9K ﹤0.01% 2665
2021
Q4 		– Sell
-7,524
Closed -$248K – 3287
2021
Q3 		$248K Sell
7,524
-2,910
-28% -$86K ﹤0.01% 2542
2021
Q2 		$307K Buy
+10,434
New +$289K ﹤0.01% 2125

Other funds holding CKPT

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HRT Financial's CKPT Position: Q3 2024 in Review

HRT Financial sold out of Checkpoint Therapeutics (CKPT) in Q3 2024, closing a stake of 21,329 shares — an estimated $45K sold.

HRT Financial first reported a position in CKPT in Q2 2021 and held it in 5 quarters. The position peaked at $307K in Q2 2021. 47 funds tracked by Wall St. Rank hold CKPT as of Q3 2024.

  • HRT Financial reported no remaining Checkpoint Therapeutics position as of Q3 2024 after selling out during the quarter.
  • HRT Financial sold 21,329 Checkpoint Therapeutics shares in Q3 2024, an estimated $45K.
  • HRT Financial first reported a position in Checkpoint Therapeutics in Q2 2021 and held it in 5 quarters.
  • HRT Financial's Checkpoint Therapeutics position peaked at $307K in Q2 2021.
  • 47 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q3 2024.

Based on HRT Financial's 13F filing for Q3 2024, filed 12 Nov 2024.